BioHarvest Sciences Inc
NASDAQ:BHST
| Market Cap (Intraday) | 145.65M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.55 |
| 50-Day MA | $7.74 |
| 200-Day MA | N/A |
BioHarvest Sciences Inc Stock, NASDAQ:BHST
625 Howe Street, Suite 1140, Vancouver, British Columbia V6C 2T6
Canada
Phone: +1.604.373.4774
Number of Employees:
Description
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.